DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
ISRCTN Registry.
A 2 × 2 factorial randomised open label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in bronchiectasis. 2018.
Accessed May 17, 2021 at:
https://doi.org/10.1186/ISRCTN89040295
We do not assume any responsibility for the contents of the web pages of other providers.